A Message from Our Founders " 2025 has been a defining year for Nimble Science. Together with our partners and clients, we’ve advanced the boundaries of GI health research, transforming curiosity into clinical and commercial impact. Thank you for your continued trust and collaboration. " Sabina & Joseph, Co-Founders, Nimble Science 2025 Highlights Regulatory Progress Health Canada Class II Medical Device License was...

CALGARY, AB — September 3, 2025 — Nimble Science, a precision medicine company with a cutting-edge data platform, announced today that it has received a Medical Device Licence from Health Canada for its SIMBA™ Capsule. This ingestible device is the first to collect targeted and preserved fluid samples from the small intestine for physiological assessment. The approval designates the SIMBA Capsule as a Class II medical device, marking a significant milestone for the company and its partners....

Nimble Science and KGK Science have signed a Letter of Intent to leverage their expertise and product offerings to build a stronger...